Pipeline

Our research and development efforts are focused on therapies for stroke and other vascular disorders, using our proprietary microbubble technology to treat vascular occlusions as well as the resulting ischemia. Our commercialization efforts are currently focused on our product approved by the U.S. Food and Drug Administration for the treatment of acute massive pulmonary embolism.